Recent News

• 03.17.2025 - FibroGen Fourth Quarter and Full Year 2024 Earnings Conference Call
• 03.17.2025 - FibroGen Fourth Quarter and Full Year 2024 Earnings Conference Call
• 03.03.2025 - FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results
• 03.03.2025 - FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results
• 03.03.2025 - FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results
• 02.20.2025 - Matthew Keller, Ph.D.
• 02.20.2025 - Matthew Keller, Ph.D.
• 02.20.2025 - FibroGen Sale of FibroGen China Conference Call
• 02.20.2025 - FibroGen Sale of FibroGen China Conference Call
• 02.20.2025 - FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million

Recent Filings

• 02.24.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 02.24.2025 - 8-K Current report
• 02.20.2025 - EX-99.1 EX-99.1
• 02.20.2025 - 8-K Current report
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors